The National Oesophago-Gastric Cancer Audit (NOGCA) was established to evaluate the quality of care received by patients diagnosed with oesophago-gastric cancer and identify areas where NHS cancer services in England and Wales can improve. Oesophago-gastric (OG) cancer is the fifth most common type of cancer in the UK, with around 13,000 people diagnosed each year in England and Wales. In addition, the Audit examines the care received by patients diagnosed with oesophageal high grade dysplasia (HGD), due to the risk of progression to cancer if HGD is left untreated.

The aim of this report is to describe the care provided by NHS OG cancer services in England and Wales from the time of diagnosis to the end of a patient’s primary treatment, and to identify regional variation in care for local investigation. It is written for those who provide, receive, commission and regulate OG cancer care. This includes clinicians and other healthcare professionals working within hospital cancer units, clinical commissioners, and regulators, as well as patients and the public who are interested in knowing how OG cancer services are delivered within the NHS. A separate summary report for the public and patients will be published in due course.

Click here to read the full 2020 report